schizophrenia – Page 61 – News and resources

Aug 15 2025

Newron randomises first subjects in Phase III programme for schizophrenia

by Clinical Editor

No Comments

“Newron randomises first subjects in Phase III programme for schizophrenia” was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Aug 15 2025

Uncategorized

RL-007 Poised to Transform CIAS Market as First Targeted Therapy for Cognitive Deficits in Schizophrenia | DelveInsight

by Clinical Editor

No Comments

As RL-007 progresses through late-stage clinical development, it represents a significant advancement in schizophrenia treatment, potentially offering one of the first approved therapies specifically …

Aug 14 2025

Uncategorized

‘I’m lucky to be alive’: Man with schizophrenia claims abuse by Warren police during mental health crisis

by Clinical Editor

No Comments

A Detroit man says he experienced cruelty and abuse during a mental health crisis encounter with Warren police.

Aug 14 2025

Uncategorized

The hidden mental health danger in today’s high-THC cannabis

by Clinical Editor

No Comments

THC levels in cannabis have soared in recent years, raising the risk of psychosis—especially in young, frequent users. Studies reveal a strong connection between cannabis-induced psychosis and schizophrenia, making early...

Aug 13 2025

Uncategorized

Scientists discover brain layers that get stronger with age

by Clinical Editor

No Comments

Researchers have discovered that parts of the human brain age more slowly than previously thought—particularly in the region that processes touch. By using ultra-high-resolution brain scans, they found that while...

Aug 13 2025

Uncategorized

Scientists reversed memory loss by powering the brain’s tiny engines

by Clinical Editor

No Comments

Scientists have discovered a direct cause-and-effect link between faulty mitochondria and the memory loss seen in neurodegenerative diseases. By creating a novel tool to boost mitochondrial activity in mouse models,...

Aug 12 2025

Uncategorized

A glutamate modulator improves schizophrenia-related dysfunction, may open new treatment paths

by Clinical Editor

No Comments

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a potential treatment for schizophrenia.

Aug 12 2025

Uncategorized